Skip to search formSkip to main contentSkip to account menu

Pivanex

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pivalyloxymethyl butyrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Dose escalation study of pivanex (a histone deacetylase inhibitor) in combination with docetaxel for advanced non-small cell lung cancer.
7279 Background: Pivanex is a histone deacetylase inhibitor that induces tumor cell differentiation and/or apoptosis. It has been… 
2004
2004
Pivanex inhibits histone deacetylase activity in non small cell lung cancer patients
4016 Pivanex™ (pivaloyloxymethyl butyrate) is a histone deacetylase (HDAC) inhibitor that distributes rapidly into tissues and… 
2004
2004
Changes to phase IIb Pivanex trial due to safety concerns
  • 2004
  • Corpus ID: 195151591
2004
2004
Changes to phase IIb Pivanex trial due to safety concerns
  • 2004
  • Corpus ID: 195112292
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)